WHAT IS THE FUTURE OF VALUE-BASED CARE?

Commercial risk will be a critical catalyst of progress – it’s complicated, but is it possible? We think so.

X

Research

How is medical evidence evolving to meet customers’ demands?

    In part 1 of our series, we explored four of the eleven trends life sciences leaders should be tracking in 2022. In part two, we take a look at five more:

    • Pushing beyond the tipping point for real-world evidence (RWE)
    • Proliferating sources of real-world data (RWD)
    • Anxiety over data privacy and security
    • Harnessing the power of AI
    • Expanding platforms for HCPs’ consumption and circulation of evidence
    Other reports in this series

    This report is part of our market trends series for life sciences leaders in 2022. Check out the other trends:

    Part 1: Situational context and market dynamics
    Part 3: Organizational impacts

    Download the full report

    • Trend 5: Pushing beyond the tipping point for real-world evidence (RWE)
    • Trend 6: Proliferating sources of real-world data (RWD)
    • Trend 7: Anxiety over data privacy and security
    • Trend 8: Harnessing the power of AI
    • Trend 9: Expanding platforms for HCPs’ consumption and circulation of evidence

    More customer insights

    For more customer insights that will shape life sciences leaders' priorities in 2022, check out: The top customer trends that life sciences leaders need to know about in 2022.

    Have a Question?

    x

    Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.